Literature DB >> 8858923

Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists.

Y Zhou1, V Gopalakrishnan, J S Richardson.   

Abstract

The fragment of beta-amyloid comprised of amino acids 25-35 induces a rapid, concentration-dependent increase in cytosolic free calcium levels in suspensions of PC12 neuronal cells. This action of beta-amyloid 25-35 is not altered by pretreatment with the calcium channel blockers nifedipine or cobalt, with the depleter of intracellular calcium stores cyclopiazonic acid, or with the phospholipase C inhibitor neomycin. However, the effects of beta-amyloid 25-35 on cytosolic free calcium are absent in calcium-free buffer and are blocked by the antioxidant lazaroid U-83836E and by vitamin E. beta-Amyloid 25-35 is also neurotoxic and produces a concentration-dependent reduction in the viability of PC12 cells in culture. The neurotoxic action of beta-amyloid is blocked by U-83836E and vitamin E but not by nifedipine or cobalt. These data indicate that both the disruption of calcium homeostasis and the reduction of cell viability produced by beta-amyloid in PC12 cells are mediated by free radical-based processes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858923     DOI: 10.1046/j.1471-4159.1996.67041419.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Protective effect of ecdysterone on PC12 cells cytotoxicity induced by beta-amyloid25-35.

Authors:  Su-fen Yang; Zhong-jun Wu; Zheng-qin Yang; Qin Wu; Qi-hai Gong; Qi-xin Zhou; Jing-shan Shi
Journal:  Chin J Integr Med       Date:  2005-12       Impact factor: 1.978

Review 2.  Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases.

Authors:  J I Kourie
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

Review 3.  Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Authors:  Nicolas Farina; David Llewellyn; Mokhtar Gad El Kareem Nasr Isaac; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2017-01-27

4.  The difference in the effect of glutamate and NO synthase inhibitor on free calcium concentration and Na+, K+-ATPase activity in synaptosomes from various brain regions.

Authors:  N F Avrova; K I Shestak; I O Zakharova; T V Sokolova; V G Leont'ev
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

Review 5.  Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Authors:  Nicolas Farina; David Llewellyn; Mokhtar Gad El Kareem Nasr Isaac; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2017-04-18

6.  The use of antioxidants to prevent glutamate-induced derangement of calcium ion metabolism in rat cerebral cortex synaptosomes.

Authors:  N F Avrova; K I Shestak; I O Zakharova; T V Sokolova; Y Y Tyurina; V A Tyurin
Journal:  Neurosci Behav Physiol       Date:  2000 Sep-Oct

Review 7.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 8.  Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Authors:  Nicolas Farina; Mokhtar Gad El Kareem Nasr Isaac; Annalie R Clark; Jennifer Rusted; Naji Tabet
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

9.  Workflow and methods of high-content time-lapse analysis for quantifying intracellular calcium signals.

Authors:  Fuhai Li; Xiaobo Zhou; Jinmin Zhu; Weiming Xia; Jinwen Ma; Stephen T C Wong
Journal:  Neuroinformatics       Date:  2008-05-28

10.  In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy.

Authors:  Megan E McLellan; Stephen T Kajdasz; Bradley T Hyman; Brian J Bacskai
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.